Erlotinib Hydrochloride CAS 183319-69-9 daahirnimo>99.0% (HPLC)
Soo saaraha hormuudka ah iyo alaab-qeybiyaha Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis (2-Methoxyethoxy) -3H-Quinazolin-4-hal CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Magaca Kiimikada | Erlotinib Hydrochloride |
La mid ah | Erlotinib HCl;Tarceva;CP-358774 Hydrochloride;6,7-Bis (2-methoxyethoxy) -4- (3-ethynylanilino) quinazoline Hydrochloride;N-(3-Ethynylphe nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amin HCl |
Lambarka CAS | 183319-69-9 |
Lambarka CAT | RF-PI2242 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C22H24ClN3O4 |
Miisaanka Molecular | 429.90 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Budada Crystalline ee Caddaan iyo Off-White |
Aqoonsiga | A: IR: Ka-hortagga Tixraaca Tixraaca B: HPLC: Ka jawaabaya Tixraaca RT |
Solubility | In yar oo Biyaha ku milmi kara, Waxoogaa ku milmi kara Methanol oo si ficil ah ugu milmi karin Acetonitrile, Acetone, Ethyl Acetate iyo Hexane |
Meesha dhalaalaysa | 223.0 ~ 229.0 ℃ |
Khasaare xagga qalajinta | <0.50% |
Hadhaaga dabka | <0.20% |
Biraha culus | <20ppm |
Xumaanta Keliya | <0.50% |
Wadarta wasakhda | <1.00% |
Xalalka Haraaga ah | |
Pyridine | <4000pm |
Chloroform | <4000pm |
DMF | <3000pm |
Daahirnimada / Habka Falanqaynta | >99.0% |
Habka Qiimaynta / Falanqaynta | 98.5% ~ 101.0% (Waxa lagu xisaabiyaa ku salaysan Anhydrous) |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | API |
Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka
Erlotinib Hydrochloride (CAS: 183319-69-9) waa molecule yar oo ka mid ah xuubka koritaanka epidermal tyrosine kinase reversible inhibitor, waxaa inta badan loo isticmaalaa daaweynta kansarka sanbabada unugyada yaryar ee gudaha ama metastatic. kansarka ganaca.Erlotinib Hydrochloride waxaa la ansixiyay bishii Noofambar, 2004, si loogu daweeyo kansarka sanbabada ee aan unugga yareyn ee sare ama metastatic.Waxay ka tirsan tahay isla fasalka Gefitinib, quinazoline kale oo loo oggolaaday daaweynta kansarka sambabada sare, laakiin leh guryaha farmashiyaha oo la hagaajiyay.Unugyada waxaa asal ahaan ka soo jeeda Pfizer waxaana la bilaabay iyadoo lala kaashanayo OSI, taasoo qaadatay xuquuq buuxda oo dawada markii Pfizer ay ku biirtay Warner Lambert.Intaa ka dib, Genentech/Roche waxay heshiis shatiga la gashay OSI si ay u horumariso oo ay ugu suuq gayso dawada Maraykanka iyo Adduunka oo dhan.Xakamaynta kobaca epidermal ee xulashada (EGFR) -tyrosine kinase inhibitor.Antineoplastic.Erlotinib Hydrochloride waa HER1/EGFR inhibitor leh IC50 ee 2 nM.Erlotinib HCl waxaa loo heli karaa sida 25-, 100-, iyo 150-mg kiniin ah maamulka afka.